Melcher AA - Search Results

1

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Among authors: melcher aa. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

2

A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model.

Castleden SA, Chong H, Garcia-Ribas I, Melcher AA, Hutchinson G, Roberts B, Hart IR, Vile RG. Castleden SA, et al. Among authors: melcher aa. Hum Gene Ther. 1997 Nov 20;8(17):2087-102. doi: 10.1089/hum.1997.8.17-2087. Hum Gene Ther. 1997. PMID: 9414257

3

Gene therapy for cancer--managing expectations.

Melcher AA, Garcia-Ribas I, Vile RG. Melcher AA, et al. BMJ. 1997 Dec 13;315(7122):1604-7. doi: 10.1136/bmj.315.7122.1604. BMJ. 1997. PMID: 9437283 Free PMC article. Review. No abstract available.

4

Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

Todryk S, Melcher AA, Hardwick N, Linardakis E, Bateman A, Colombo MP, Stoppacciaro A, Vile RG. Todryk S, et al. Among authors: melcher aa. J Immunol. 1999 Aug 1;163(3):1398-408. J Immunol. 1999. PMID: 10415040

5

Heat shock proteins refine the danger theory.

Todryk SM, Melcher AA, Dalgleish AG, Vile RG. Todryk SM, et al. Among authors: melcher aa. Immunology. 2000 Mar;99(3):334-7. doi: 10.1046/j.1365-2567.2000.00002.x. Immunology. 2000. PMID: 10712661 Free PMC article. No abstract available.

6

Cancer gene therapy: developments to 2000.

Bateman AR, Harrington KJ, Melcher AA, Vile RG. Bateman AR, et al. Among authors: melcher aa. Expert Opin Investig Drugs. 2000 Dec;9(12):2799-813. doi: 10.1517/13543784.9.12.2799. Expert Opin Investig Drugs. 2000. PMID: 11093354 Review.

7

Macrophages orchestrate the immune response to tumor cell death.

Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. Gough MJ, et al. Among authors: melcher aa. Cancer Res. 2001 Oct 1;61(19):7240-7. Cancer Res. 2001. PMID: 11585761

8

Cancer gene therapy: Part 1. Vector development and regulation of gene expression.

Harrington KJ, Bateman AR, Melcher AA, Ahmed A, Vile RG. Harrington KJ, et al. Among authors: melcher aa. Clin Oncol (R Coll Radiol). 2002 Feb;14(1):3-16. doi: 10.1053/clon.2001.0002. Clin Oncol (R Coll Radiol). 2002. PMID: 11898782 Review. No abstract available.

9

Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.

Harrington KJ, Melcher AA, Bateman AR, Ahmed A, Vile RG. Harrington KJ, et al. Among authors: melcher aa. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):148-69. doi: 10.1053/clon.2001.0004. Clin Oncol (R Coll Radiol). 2002. PMID: 12069125 Review. No abstract available.

10

Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein.

Kirkham LA, Bateman AR, Melcher AA, Vile RG, Fielding AK. Kirkham LA, et al. Among authors: melcher aa. J Gene Med. 2002 Nov-Dec;4(6):592-600. doi: 10.1002/jgm.306. J Gene Med. 2002. PMID: 12439851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters